Summary
The response to 40 mg furosemide p.o. in 6 healthy kidney donors and 6 renal transplant recipients with and without naproxen pretreatment has been studied. No volume replacement was given in order to study the development of tolerance. The subjects showed an average dehydration of 1.5 kg · 6 h−1.
While mean creatinine clearance was equal in patients and donors (76 vs 80 ml/min), renal furosemide clearance was significantly lower in the patients (47 vs 81 ml/min; P<0.05). The patients also excreted a smaller fraction of the dose in the urine (5.7 vs 7.8 mg/6 h; P<0.05). As the overall renal sensitivity was similar in the two groups, the natriuretic response was correspondingly smaller in transplant recipients as compared to donors.
Within the observation period of 6 h after dosing, acute tolerance developed in the donors and in 4 of the 6 patients, as shown by clockwise hysteresis in the dose (urine furosemide excretion rate)-response (natriuresis) curves. Pretreatment with naproxen reduced renal sensitivity to furosemide (right shift of the dose response curve) in all the donors but in only 2 of the patients.
In both groups acute tolerance was less pronounced after naproxen, which may indicate involvement of the prostaglandin system in the development of acute tolerance. The results may also indicate regeneration of sympathetic nerves with functional capacity in at least some renal transplants, or that other mechanisms of salt regulation compensate for loss of sympathetic nerve activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hammarlund MM, Odlind B, Paalzow LK (1985) Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 233: 447–453
Sjöström P, Odlind B, Beermann B, Hammarlund-Udenaes M (1988) On the mechanism of acute tolerance to furosemide diuresis. Scand J Urol Nephrol 22: 133–140
Hammarlund MM, Paalzow LK, Odlind B (1984) Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur J Clin Pharmacol 26: 197–207
Grahnén A, Hammarlund M, Lundqvist T (1984) Implications of intraindividual variability in bioavailability studies of furosemide. Eur J Clin Pharmacol 27: 595–602
Gehr TWB, Sica DA, Brater DC, Davis J, Fakhry I (1988) Furosemide pharmacokinetics and pharmacodynamics in renal transplantation. Clin Pharmacol Ther 43: 547–553
Smith DE, Gambertoglio JG, Vincenti F, Benet LZ (1981) Furosemide kinetics and dynamics after kidney transplant. Clin Pharmacol Ther 30: 105–113
Sjöström P, Beermann B, Odlind B (1987) Pharmacokineticpharmacodynamic relationship of piretanide in healthy and uremic subjects. Determinants of the diuretic effect of a loop diuretic. Scand J Urol Nephrol 21: 55–64
Brater DC, Anderson SA, Brown-Cartwright D (1986) Response to furosemide in chronic renal insufficiency: Rationale for limited doses. Clin Pharmacol Ther 40: 134–139
Sjöström P, Odlind B, Beermann B (1989) Pharmacokinetics and effects of furosemide in patients with nephrotic syndrome. Eur J Clin Pharmacol 37: 173–180
Danielsen H, Pedersen EB, Madsen M, Jensen T (1985) Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate. Acta Med Scand 217: 513–518
Chennavasin P, Seiwell R, Brater DC (1980) Pharmacokineticdynamic analysis of indomethacin-furosemide interaction in man. J Pharmacol Exp Ther 215: 77–81
Brater DC, Anderson SA, Baird B, Campbell WB (1985) Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int 27: 66–73
Henrich WL, Anderson RJ, Berns AS, McDonald KM, Paulsen PJ, Berl T, Schrier RW (1978) The Role of Renal Nerves and Prostaglandins in Control of Renal Hemodynamics and Plasma Renin Activity during Hypotensive Hemorrhage in the Dog. J Clin Invest 61: 744–750
Zawada ET (1984) The Adaptive Role of Renal Prostaglandin Production: Current Clinical Problems and Future Clinical Horizons. Nephron 36: 77–79
Ciobattoni G, Pugliese F, Cinotti GA et al. (1979) Characterization of furosemide induced activation of the renal prostaglandin system. Eur J Pharmacol 60: 181–187
Blaufox MD, Lewis EJ, Jagger P, Lauler D, Hickler R, Merrill JP (1969) Physiologic responses of the transplanted human kidney. Sodium regulation and renin secretion. N Engl J Med 280: 62–66
Gazdar AF, Dammin GF (1970) Neural degeneration and regeneration in human renal transplants. N Engl J Med 283: 222–224
Girchev RA, Natcheff ND (1988) Excretory function after renal denervation and administration of diuretics to unesthetized dogs. Biomed Biochim Acta 47: 507–514
Hall S, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263–268
Bergström J, Bucht H, Ek J, Josephson B, Sundell H, Werkö L (1959) The renal excretion of para-aminohippurate in normal persons and in patients with diseased kidneys. Scand J Clin Lab Invest 11: 361–375
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sjöström, P.A., Odlind, B.G. & Hammarlund-Udenaes, M. Response to furosemide during dehydration with and without naproxen pretreatment of kidney donors and renal transplant recipients. Eur J Clin Pharmacol 40, 209–214 (1991). https://doi.org/10.1007/BF00315197
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315197